Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

BGICC 2023: Breast contouring workshop

BGICC 2023

19 - 20 Jan 2023

Published: 2 Feb 2023

Views: 11

Rating:

Save

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium

Prof Philip Poortmans speaks to ecancer about his breast cancer contouring workshop at the BGICC 2023.

He expressed the importance of target volume definition and delineation for the best overall cosmetic outcome.

Related Videos

IORT at the Asian Hospital and Medical Center

Dr Aldine Basa - Asian Hospital and Medical Center, Manila, Philippines

IORT at the Asian Hospital and Medical Center ( Dr Aldine Basa - Asian Hospital and Medical Center, Manila, Philippines )

IORT at Institute Paoli-Calmettes in France

Dr Agnes Tallet - Institute Paoli-Calmettes, Marseille, France

IORT at Institute Paoli-Calmettes in France ( Dr Agnes Tallet - Institute Paoli-Calmettes, Marseille, France )

INTRAGO: Intraoperative radiotherapy in newly diagnosed glioblastoma

Dr Frank Giordano - University of Heidelberg, Heidelberg, Germany

INTRAGO: Intraoperative radiotherapy in newly diagnosed glioblastoma ( Dr Frank Giordano - University of Heidelberg, Heidelberg, Germany )

IORT at hospital Del Mar Barcelona in Spain

Dr Javier Sanz - Hospital Del Mar, Barcelona, Spain

IORT at hospital Del Mar Barcelona in Spain ( Dr Javier Sanz - Hospital Del Mar, Barcelona, Spain )

IORT at University Hospital Augsburg in Germany

Dr Klaus-Henning Kahl - University Hospital Augsburg, Augsburg, Germany

IORT at University Hospital Augsburg in Germany ( Dr Klaus-Henning Kahl - University Hospital Augsburg, Augsburg, Germany )

Comment: Artificial Intelligence and surgical management of Axilla

Prof Mehra Golshan - Yale School of Medicine, New Haven, USA

Comment: Artificial Intelligence and surgical management of Axilla ( Prof Mehra Golshan - Yale School of Medicine, New Haven, USA )

HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan

Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston...

HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan ( Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston, USA )

Cancer Services Delivery: Focus on India

Dr Soumitra Datta - Tata Medical Center, Kolkata, India

Cancer Services Delivery: Focus on India ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )

The optimal approach after neoadjuvant treatment: The Lucerne toolbox

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal

The optimal approach after neoadjuvant treatment: The Lucerne toolbox ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )

More from ecancer